This study established the first evidence of Mxene-bpV’sneuroprotective effects against cerebral ischemia-reperfusion injury via a reduction in the levels of pro-inflammatory cytokines, including IL-1β, IL-6 and TNF-α. The gene discussed is TNF; the disease is injury.